866-997-4948(US-Canada Toll Free)

Anti-Venom Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Dec 2017

Category :

Pharmaceutical

No. of Pages : 192 Pages

Global Anti-venom Market: Overview

This report on anti-venom market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of anti-venom products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global anti-venom market with respect to the leading market segments based on anti-venom type,

Global Anti-venom Market: Key Segments

The global anti-venom market is divided into: by transplant type, by anti-venom type, by product type, distribution channel and by geography. Anti-venom type segment was divided into monovalent and polyvalent anti-venom. On the basis of product type, the market was divided into snake anti-venom, scorpion anti-venom, spider anti-venom and other anti-venoms. Other anti-venoms include anti-venoms against fish stings, such as jellyfish and sting rays. On the basis of distribution channel the anti-venom market is divided into hospitals, clinics, ambulatory surgical centers, and others.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2017 to 2025, along with the compound annual growth rate (CAGR %) from 2017 to 2025) are provided for all segments, considering 2016 as the base year.

Global Anti-venom Market: Scope of the Study

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global anti-venom market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different transplants/disease indication/applications/geographies. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Anti-venom Market: Regional Outlook

Geographically, the anti-venom market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for anti-venom market has been further categorized into major anti-venom type, product type, and distribution channel segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn along with CAGR % from 2017 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Companies Mentioned in Report

The report profiles key manufacturers in the anti-venom market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include CSL Behring, Bharat Serums and Vaccines Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd, Vacsera, Vins Bioproducts Limited, Rare Therapeutics, etc.

The anti-venom market has been segmented as follows:

  • Anti-venom Market by Anti-venom type
    • Monovalent
    • Polyvalent
       
  • Anti-venom Market n by Product Type
    • Snake anti-venom
    • Scorpion anti-venom
    • Spider anti-venom
    • Others
       
  • Anti-venom Market n by Distribution Channel
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Others
       
  • The Anti-venom Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

Table of Content

Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Anti-venom Market   

Chapter 4. Market Overview
4.1. Introduction
4.1.1. Anti-Venom Type Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Anti-venom Market Analysis and Forecast, 2016 – 2024
4.4.1. Pricing – Actuals and Projections, 2016-2024 (US$)
4.4.2. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
4.6. Value Chain Analysis
4.7. Market Outlook

Chapter 5. Global Anti-venom Market Analysis and Forecasts, By Anti-Venom Type
5.1. Introduction & Definition
5.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
5.2.1. Monovalent
5.2.2. Polyvalent
5.3. Market Attractiveness By Anti-Venom Type  
5.4. Key Trends

Chapter 6. Global Anti-venom Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Market Size (US$ Mn) Forecast By Product Type
6.2.1. Snake Anti-Venom
6.2.2. Scorpion Anti-Venom
6.2.3. Spider Anti-Venom
6.2.4. Others
6.3. Market Attractiveness By Product Type  
6.4. Key Trends

Chapter 7. Global Anti-venom Market Analysis and Forecasts, By Distribution Channel
7.1. Introduction & Definition
7.2. Market Size (US$ Mn) Forecast By Distribution Channel
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Ambulatory Surgical centers
7.2.4. Others
7.3. Market Attractiveness By Distribution Channel
7.4. Key Trends

Chapter 8. Global Anti-venom Market Analysis and Forecasts, By Region
8.1. Introduction & Definition
8.2. Market Size (US$ Mn) Forecast By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Europe
8.2.4. Asia Pacific 
8.2.5. Middle East and Africa
8.3. Market Attractiveness By Region
8.4. Key Trend

Chapter 9. North America Anti-venom Market Analysis and Forecast
9.1. Introduction
9.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
9.2.1. Monovalent
9.2.2. Polyvalent
9.3. Market Size (US$ Mn) Forecast By Product Type
9.3.1. Snake Anti-Venom
9.3.2. Scorpion Anti-Venom
9.3.3. Spider Anti-Venom
9.3.4. Others
9.4. Market Size (US$ Mn) Forecast By Distribution Channel
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical centers
9.4.4. Others
9.5. Market Size (US$ Mn) Forecast, By Country
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis 
9.6.1. By Anti-Venom Type
9.6.2. By Product Type
9.6.3. By Distribution Channel
9.6.4. By Country
9.7. Key Trend

Chapter 10. Europe Anti-venom Market Analysis and Forecast
10.1. Introduction
10.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
10.2.1. Monovalent
10.2.2. Polyvalent
10.3. Market Size (US$ Mn) Forecast By Product Type
10.3.1. Snake Anti-Venom
10.3.2. Scorpion Anti-Venom
10.3.3. Spider Anti-Venom
10.3.4. Others
10.4. Market Size (US$ Mn) Forecast By Distribution Channel
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical centers
10.4.4. Others
10.5. Market Size (US$ Mn) Forecast, By Country
10.5.1. U.K.
10.5.2. France
10.5.3. Germany
10.5.4. Spain
10.5.5. Rest of Europe
10.6. Market Attractiveness Analysis 
10.6.1. By Anti-Venom Type
10.6.2. By Product Type
10.6.3. By Distribution Channel 
10.6.4. By Country 
10.7. Key Trend 

Chapter 11. Asia Pacific Anti-venom Market Analysis and Forecast
11.1. Introduction
11.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
11.2.1. Monovalent
11.2.2. Polyvalent
11.3. Market Size (US$ Mn) Forecast By Product Type
11.3.1. Snake Anti-Venom
11.3.2. Scorpion Anti-Venom
11.3.3. Spider Anti-Venom
11.3.4. Others
11.4. Market Size (US$ Mn) Forecast By Distribution Channel
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical centers
11.4.4. Others
11.5. Market Size (US$ Mn) Forecast, By Country
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Rest of APAC
11.6. Market Attractiveness Analysis 
11.6.1. By Anti-Venom Type
11.6.2. By Product Type
11.6.3. By Distribution Channel
11.6.4. By Country 
11.7. Key Trend 

Chapter 12. Latin America Anti-venom MarketAnalysis and Forecast
12.1. Introduction
12.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
12.2.1. Monovalent
12.2.2. Polyvalent
12.3. Market Size (US$ Mn) Forecast By Product Type
12.3.1. Snake Anti-Venom
12.3.2. Scorpion Anti-Venom
12.3.3. Spider Anti-Venom
12.3.4. Others
12.4. Market Size (US$ Mn) Forecast By Distribution Channel
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical centers
12.4.4. Others
12.5. Market Size (US$ Mn) Forecast, By Country
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
12.6. Market Attractiveness Analysis 
12.6.1. By Anti-Venom Type
12.6.2. By Product Type
12.6.3. BY Distribution Channel
12.6.4. By Country 
12.7. Key Trend 

Chapter 13. Middle East & Africa Anti-venom MarketAnalysis and Forecast
13.1. Introduction
13.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
13.2.1. Monovalent
13.2.2. Polyvalent
13.3. Market Size (US$ Mn) Forecast By Product Type
13.3.1. Snake Anti-Venom
13.3.2. Scorpion Anti-Venom
13.3.3. Spider Anti-Venom
13.3.4. Others
13.4. Market Size (US$ Mn) Forecast By Distribution Channel
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical centers
13.4.4. Others
13.5. Market Size (US$ Mn) Forecast, By Country
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. Rest of MEA
13.6. Market Attractiveness Analysis 
13.6.1. By Anti-Venom Type
13.6.2. By Product Type
13.6.3. BY Distribution Channel
13.6.4. By Country 
13.7. Key Trend 

Chapter 14. Competition Landscape
14.1. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.1.1. CSL Behring
14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.1.2. Product Portfolio
14.1.1.3. SWOT Analysis
14.1.1.4. Strategic Overview
14.1.2. Bharat Serums and Vaccines Ltd
14.1.2.1.Company Overview (HQ, Business Segments, Employee Strength)
14.1.2.2. Product Portfolio
14.1.2.3. SWOT Analysis
14.1.2.4. Strategic Overview
14.1.3. Haffkine Bio-Pharmaceutical Corporation Ltd 
14.1.3.1. Company Overview 
14.1.3.2. Product Portfolio
14.1.3.3. SWOT Analysis
14.1.3.4. Financial Overview
14.1.3.5. Strategic Overview
14.1.4. Vacsera 
14.1.4.1. Company Overview 
14.1.4.2. Product Portfolio
14.1.4.3. SWOT Analysis
14.1.4.4. Financial Overview
14.1.4.5. Strategic Overview
14.1.5. Vins Bioproducts Limited
14.1.5.1. Company Overview 
14.1.5.2. Product Portfolio
14.1.5.3. SWOT Analysis
14.1.5.4. Financial Overview
14.1.5.5. Strategic Overview
14.1.6. Rare Disease Therapeutics, Inc.  
14.1.6.1. Company Overview 
14.1.6.2. Product Portfolio
14.1.6.3. SWOT Analysis
14.1.6.4. Financial Overview
14.1.6.5. Strategic Overview
14.1.7. Bharat Biotech
14.1.7.1. Company Overview 
14.1.7.2. Product Portfolio
14.1.7.3. SWOT Analysis
14.1.7.4. Financial Overview
14.1.7.5. Strategic Overview
14.1.8. BTG International Ltd.
14.1.8.1. Company Overview 
14.1.8.2. Product Portfolio
14.1.8.3. SWOT Analysis
14.1.8.4. Financial Overview
14.1.8.5. Strategic Overview

Chapter 15. Key Takeaways

List of Table

Table 01: Global Anti-venom Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 02: Global Anti-venom Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 03: Global Anti-venom Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 04: Global Anti-venom Market Size (US$ Mn) Forecast, by Region,
Table 05: Asia Pacific Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 06: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 07: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 08: Asia Pacific Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 09: Middle East & Africa Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 10: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 12: Middle East & Africa Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 13: Latin America Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 14: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 15: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Latin America Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 17: North America Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 18: North America Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 20: North America Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 21: Europe Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 22: Europe Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 23: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 24: Europe Anti-venom Market Size (US$ Mn) Forecast, by Country,

List of Chart

Figure 01: Global Anti-venom Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Global Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 03: Global Monovalent Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 04: Global Polyvalent Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 05: Global Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 06: Global Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025 
Figure 07: Global Snake Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 08: Global Scorpion Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 09: Global Spider Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Other Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 13: Global Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 14: Global Hospitals Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: Global Clinics Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Ambulatory Surgical Centers Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Other Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Anti-Venom Market Attractiveness Analysis, by Distribution Channel
Figure 19: Global Anti-Venom Market Value Share Analysis, by Region, 2017 and 2025 
Figure 20: Asia Pacific Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Middle East & Africa Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Latin America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 23: North America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 24: Europe Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Anti-Venom Market Attractiveness Analysis, by Region
Figure 26: Asia Pacific Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Asia Pacific Anti-Venom Market Attractiveness Analysis, by Country
Figure 28: Asia Pacific Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 29: Asia Pacific Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 30: Asia Pacific Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 31: Asia Pacific Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 32: Asia Pacific Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 33: Asia Pacific Anti-venom Market Attractiveness Analysis, by Product Type
Figure 34: Asia Pacific Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 35: Asia Pacific Anti-venom Market Attractiveness Analysis, by Country
Figure 36: Middle East & Africa Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 37: Middle East & Africa Anti-Venom Market Attractiveness Analysis, by Country
Figure 38: Middle East & Africa Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 39: Middle East & Africa Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 40: Middle East & Africa Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 41: Middle East & Africa Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 42: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 43: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Product Type
Figure 44: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 45: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Country
Figure 46: Latin America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 47: Latin America Anti-Venom Market Attractiveness Analysis, by Country
Figure 48: Latin America Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 49: Latin America Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 50: Latin America Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 51: Latin America Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 52: Latin America Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 53: Latin America Anti-venom Market Attractiveness Analysis, by Product Type
Figure 54: Latin America Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 55: Latin America Anti-venom Market Attractiveness Analysis, by Country
Figure 56: North America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 57: North America Anti-Venom Market Attractiveness Analysis, by Country
Figure 58: North America Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 59: North America Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 60: North America Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 61: North America Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 62: North America Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 63: North America Anti-venom Market Attractiveness Analysis, by Product Type
Figure 64: North America Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 65: North America Anti-venom Market Attractiveness Analysis, by Country
Figure 66: Europe Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 67: Europe Anti-Venom Market Attractiveness Analysis, by Country
Figure 68: Europe Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 69: Europe Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 70: Europe Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 71: Europe Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 72: Europe Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 73: Europe Anti-venom Market Attractiveness Analysis, by Product Type
Figure 74: Europe Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 75: Europe Anti-venom Market Attractiveness Analysis, by Country
Figure 76: Breakdown of Net Sales (2015), by Segments: CSL Behring
Figure 77: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: CSL Behring
Figure 78: Breakdown of Net Sales (2015), by Segments: Bharat Serums and Vaccines Ltd
Figure 79: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Bharat Serums and Vaccines Ltd
Figure 80: Breakdown of Net Sales (2015), by Segments: Haffkine Bio-Pharmaceutical Corporation Ltd
Figure 81: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Haffkine Bio-Pharmaceutical Corporation Ltd
Figure 82: Breakdown of Net Sales (2015), by Segments: Vacsera
Figure 83: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Vacsera
Figure 84: Breakdown of Net Sales (2015), by Segments: Vins Bioproducts Limited
Figure 85: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Vins Bioproducts Limited
Figure 86: Breakdown of Net Sales (2015), by Segments: Rare Disease Therapeutics, Inc.  
Figure 87: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Rare Disease Therapeutics, Inc.  
Figure 88: Breakdown of Net Sales (2015), by Segments: Bharat Biotech 
Figure 89: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Bharat Biotech
Figure 90: Breakdown of Net Sales (2015), by Segments: BTG International Ltd.
Figure 91: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: BTG International Ltd.

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *